NGNE Competitors & Alternatives
Compare Neurogene Inc with similar stocks in the same industry
Biotechnology
NGNE
Main Stock$32.87
Tradestie Score
55
Market Cap
$256.54M
Analyst Upside
+148.6%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$32.04
|
$715.25M | - | 46 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$140.78
|
$699.30M | - | 51 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.11
|
$688.47M | - | 45 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.06
|
$670.30M | - | 54 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.88
|
$665.30M | - | 58 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.84
|
$626.91M | - | 51 | Compare |
|
SVRA
Savara Inc.
|
$5.33
|
$611.84M | - | 58 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
More NGNE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry